Skip to main content
. 2018 Sep 20;50(3):238–251. doi: 10.3947/ic.2018.50.3.238

Table 1. Descriptive statistics for the ocular outcome of endogenous endophthalmitis.

Total of 39 EE patients (23 culture positive cases and 16 culture negative cases)
Variables Good ocular outcomea N = 19 (%) Poor ocular outcomeb N = 20 (%) Total N = 39 (%) P-value
Gender 1.000
Female 6 (31.6) 6 (30.0) 12 (30.8)
Male 13 (68.4) 14 (70.0) 27 (69.2)
Age 0.250
≤60 years 13 (68.4) 9 (45.0) 22 (56.4)
>60 years 6 (31.6) 11 (55.0) 17 (43.6)
Predisposing disease 1.000
Yes 16 (84.2) 17 (85.0) 33 (84.6)
No 3 (15.8) 3 (15.0) 6 (15.4)
Diabetes mellitus 1.000
Yes 6 (31.6) 7 (35.0) 13 (33.3)
No 13 (68.4) 13 (65.0) 26 (66.7)
Malignancy 0.308
Yes 4 (21.1) 1 (5.0) 5 (12.8)
No 15 (78.9) 19 (95.0) 34 (87.2)
Indwelling catheter 1.000
Yes 2 (10.5) 2 (10.0) 4 (10.3)
No 17 (89.5) 18 (90.0) 35 (89.7)
Liver abscess 0.399
Yes 6 (31.6) 10 (50.0) 16 (41.0)
No 13 (68.4) 10 (50.0) 23 (59.0)
Acute pyelonephritis 0.350
Yes 4 (21.1) 8 (40.0) 12 (30.8)
No 15 (78.9) 12 (60.0) 27 (69.2)
Klebsiella as pathogen 0.020
No 17 (89.5) 10 (50.0) 27 (69.2)
Yes 2 (10.5) 10 (50.0) 12 (30.8)
Pathogens in culture 0.646
No growth 9 (47.4) 7 (35.0) 16 (41.0)
Growth 10 (52.6) 13 (65.0) 23 (59.0)
Diagnosis after symptom onset 0.129
≤3 days 13 (72.2) 8 (42.1) 21 (56.8)
>3 days 5 (27.8) 11 (57.9) 16 (43.2)
Antibiotic treatment after symptom onset 0.259
≤4 days 14 (82.4) 10 (58.8) 24 (70.6)
>4 days 3 (17.6) 7 (41.2) 10 (29.4)
Surgical procedurec after symptom onset 0.990
≤5 days 10 (71.4) 11 (64.7) 21 (67.7)
>5 days 4 (28.6) 6 (35.3) 10 (32.3)
C-reactive protein (mg/dL) 0.539
≤10 5 (33.3) 3 (17.6) 8 (25.0)
>10 10 (66.7) 14 (82.4) 24 (75.0)

EE, endogenous endophthalmitis.

aHand motion, counting fingers, and 20/200 or better.

bNo light perception and light perception.

cIntravitreal antibiotics or pars plana vitrectomy.